Statistics for Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis

Total visits

views
Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis 53

Total visits per month

views
May 2025 0
June 2025 0
July 2025 0
August 2025 0
September 2025 0
October 2025 0
November 2025 0

File Visits

views
Open-Label Phase 3 Study of Intravenous Golimumab.pdf 28

Top country views

views
United States 42
Chile 1
India 1
Mexico 1

Top city views

views
Miami 30
Alameda 2
Bangalore 1
Santiago 1
Zapopan 1